LWCFA
XLRN

Loring Wolcott & Coolidge Fiduciary Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-330
Closed -$57K 787
2021
Q3
$57K Sell
330
-21
-6% -$3.63K ﹤0.01% 451
2021
Q2
$44K Buy
+351
New +$44K ﹤0.01% 482
2021
Q1
Sell
-337
Closed -$43K 767
2020
Q4
$43K Hold
337
﹤0.01% 445
2020
Q3
$38K Hold
337
﹤0.01% 424
2020
Q2
$32K Hold
337
﹤0.01% 415
2020
Q1
$30K Hold
337
﹤0.01% 422
2019
Q4
$18K Hold
337
﹤0.01% 548
2019
Q3
$13K Hold
337
﹤0.01% 553
2019
Q2
$14K Hold
337
﹤0.01% 544
2019
Q1
$16K Hold
337
﹤0.01% 537
2018
Q4
$15K Hold
337
﹤0.01% 543
2018
Q3
$19K Hold
337
﹤0.01% 500
2018
Q2
$16K Hold
337
﹤0.01% 519
2018
Q1
$13K Hold
337
﹤0.01% 572
2017
Q4
$14K Hold
337
﹤0.01% 550
2017
Q3
$13K Hold
337
﹤0.01% 546
2017
Q2
$11K Hold
337
﹤0.01% 543
2017
Q1
$9K Hold
337
﹤0.01% 559
2016
Q4
$9K Hold
337
﹤0.01% 543
2016
Q3
$12K Hold
337
﹤0.01% 534
2016
Q2
$11K Buy
+337
New +$11K ﹤0.01% 539